drugset / Trial / NCT00038545
A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
For patients with relapsed and refractory aggressive non-Hodgkin's lymphoma
Timeline
- Start
- 2001-05-18
- Primary completion
- 2004-04-27
- Completion
- 2004-04-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paclitaxel | Small molecule | — | — |
| Subject | Topotecan | Small molecule | — | — |
| Background | Filgrastim SD/01 | Unknown | — | — |